Dr. Ashish Kumar Agrawal obtained his PhD from the National Institute of Pharmaceutical Education and Research, SAS Nagar, and completed a post-doctorate at the University of Louisville, Kentucky, USA. He has been associated with the Department of Pharmaceutical Engineering and Technology, IIT (BHU), since May 2018. During his research career, he has worked on many formulation strategies for the oral delivery of chemotherapeutics. He has more than 100 publications, with a total impact factor of ~400 in high-impact peer-reviewed journals (h-index: 40 and more than 5000 citations) and has received several national and international awards for his extraordinary contributions to the field.
Indian Institute of Technology BHU
Vārānasi, Uttar Pradesh, International

Outstanding Reviewer Award
MDPI
Awarded by Pharmaceutics in 2022